Revenio Group Oyj (REG1V):企業の財務・戦略的SWOT分析

◆英語タイトル:Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME241719FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Revenio Group Oyj (REG1V) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Revenio Group Oyj (Revenio) is a provider of health tech screening devices that focus on ophthalmic diagnostic solutions. The company focuses on early detection of glaucoma, asthma, skin cancer and macular degeneration. The company’s major products include devices for detecting age-related eye diseases which include glaucoma, diabetic retinopathy, macular degeneration and cataracts. Revenio offers its products to ophthalmologists, opticians and optometrists. The company has operations in Europe, America, and Asia. Revenio is headquartered in Vantaa, Finland.

Revenio Group Oyj Key Recent Developments

Oct 22,2020: Revenio Group : Interim report, January 1 – September 30, 2020
Oct 21,2020: Revenio Group board of directors established a nomination and remuneration committee
Aug 06,2020: Revenio Group Corporation: Half-year financial report, January 1 – June 30, 2020
Apr 22,2020: Revenio Group : Interim report, January 1 – March 31, 2020
Mar 31,2020: Jouni Toijala appointed as the CEO of Revenio Group

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Revenio Group Oyj – Key Facts
Revenio Group Oyj – Key Employees
Revenio Group Oyj – Key Employee Biographies
Revenio Group Oyj – Major Products and Services
Revenio Group Oyj – History
Revenio Group Oyj – Company Statement
Revenio Group Oyj – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Revenio Group Oyj – Business Description
Geographical Segment: Finland
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Others
Performance
R&D Overview
Revenio Group Oyj – Corporate Strategy
Revenio Group Oyj – SWOT Analysis
SWOT Analysis – Overview
Revenio Group Oyj – Strengths
Revenio Group Oyj – Weaknesses
Revenio Group Oyj – Opportunities
Revenio Group Oyj – Threats
Revenio Group Oyj – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Revenio Group Oyj, Medical Equipment, Deals By Year, 2014 to YTD 2020
Revenio Group Oyj, Medical Equipment, Deals By Type, 2014 to YTD 2020
Revenio Group Oyj, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 22, 2020: Revenio Group : Interim report, January 1 – September 30, 2020
Oct 21, 2020: Revenio Group board of directors established a nomination and remuneration committee
Aug 06, 2020: Revenio Group Corporation: Half-year financial report, January 1 – June 30, 2020
Apr 22, 2020: Revenio Group : Interim report, January 1 – March 31, 2020
Mar 31, 2020: Jouni Toijala appointed as the CEO of Revenio Group
Nov 25, 2019: Revenio Group Corporation – Changes in management
Aug 15, 2019: Revenio Group : Half-year financial report
Apr 16, 2019: Revenio Group: Interim Report January 1- March 31, 2019
Apr 15, 2019: Revenio Group: Mikko Moilanen appointed as Revenio’s CEO
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Revenio Group Oyj, Key Facts
Revenio Group Oyj, Key Employees
Revenio Group Oyj, Key Employee Biographies
Revenio Group Oyj, Major Products and Services
Revenio Group Oyj, History
Revenio Group Oyj, Subsidiaries
Revenio Group Oyj, Key Competitors
Revenio Group Oyj, Ratios based on current share price
Revenio Group Oyj, Annual Ratios
Revenio Group Oyj, Annual Ratios (Cont...1)
Revenio Group Oyj, Annual Ratios (Cont...2)
Revenio Group Oyj, Interim Ratios
Revenio Group Oyj, Medical Equipment, Deals By Year, 2014 to YTD 2020
Revenio Group Oyj, Medical Equipment, Deals By Type, 2014 to YTD 2020
Revenio Group Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Revenio Group Oyj (REG1V):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kvaerner ASA (KVAER):企業の財務・戦略的SWOT分析
    Kvaerner ASA (KVAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cerus Corp (CERS):製薬・医療:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Astute Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Thirumalai Chemicals Ltd (TIRUMALCHM):企業の財務・戦略的SWOT分析
    Thirumalai Chemicals Ltd (TIRUMALCHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpati …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Quest Diagnostics Inc (DGX):医療機器:M&Aディール及び事業提携情報
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Cyient Ltd (CYIENT):企業の財務・戦略的SWOT分析
    Cyient Ltd (CYIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Mega Uranium Ltd. (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd. (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent he …
  • Paychex, Inc.:企業の戦略・SWOT・財務情報
    Paychex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Paychex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Orion Corp (ORNBV):企業の財務・戦略的SWOT分析
    Orion Corp (ORNBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Novacyt SA (ALNOV):企業の製品パイプライン分析2018
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • REVA Medical Inc (RVA):企業の財務・戦略的SWOT分析
    Summary REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It off …
  • Jardine Cycle & Carriage Ltd (C07):企業の財務・戦略的SWOT分析
    Jardine Cycle & Carriage Ltd (C07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Haisheng Juice Holdings Co Ltd:企業の戦略・SWOT・財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆